Today is a relatively interesting day for the biotech world; and looking at the stocks in the space, there are several possibly profitable opportunities starting to emerge. With that said, today we’re going to look at the 4 different biotech stocks that I think are presenting the largest opportunities at the moment. Here’s what I see…
Aoxing Pharmaceutical Company Stock Is Down | Not For Long
Aoxing Pharmaceutical Company Inc (NYSEMKT: AXN)
Aoxing Pharmaceutical Company had a great day on Monday following the weekend news that it would be giving an important company update at the New York Stock Exchange on Tuesday. Unfortunately however, the update was a bit of a flop. So, on Tuesday, Wednesday, and now today, AXN is falling in the market. However, those that see the intrinsic value in the stock are likely to see gains; and I’m expecting to see it pop back up either later today, tomorrow, or early next week. Currently (12:09), AXN is trading at $2.30 a point at which the stock has reached support recently. It’s time for this thing to start popping back up; so look for the uptrends to come for big growth opportunities.
Opexa Therapeutics Stock Is Likely To Continue Gains
Opexa Therapeutics Inc (NASDAQ: OPXA)
Opexa Therapeutics has had a great time in the market over the past few weeks; showing massive gains. Most recently, the company climbed following news of a the fact that they’ve hired a well respected physician, Dr. Jason Kralic as the Vice President of Business Development. Regardless of the hire, I am impressed with Opexa as a company; so, the new hire makes them even that much stronger. Currently, the stock is continuing uptrends; and likely to continue doing so for some time. So, look for pull backs as they are likely to signify great buying opportunities.
Gilead Sciences Stock Has Reached A New Lifetime High
Gilead Sciences, Inc (NASDAQ: GILD)
Gilead Sciences has been on a strong bullish run recently; and that bullish run has pushed the stock to a new lifetime high. With strong flagship products, an incredibly talented team, and overwhelmingly bullish opinions from analysts on the stock, I’m expecting to continue to see growth from GILD. So, this is another one that’s worth watching closely for pull backs and great buying opportunities.
Galena Biopharma Stock Drops Back From Its Bullish Trend
Galena Biopharma Inc (NASDAQ: GALE)
Finally, Galena Biopharma has looked amazing over the past two weeks. As a matter of fact, in that time, the stock has grown by around 58%. However, we seem to be seeing a different story from GALE today as the stock seems to be going through a slight correction. I’m not expecting these declines to last long. After the presentations at this year’s ASCO conference and positive commentary from Maxim Group that we’ve seen recently, I’m expecting more bullish activity to come. So, watch for support as it will be a great entrance point to get in on the gains.
Do You Know Of Any Others?
Do you know of any other hot opportunities in the biotech market? If so, let us know in the comments below!